Clinical Utility of Genomic Analysis in the Diagnosis and Management of Liver Disease

Nov 18 2024

Convention Center: Room 28 E

7:00 AM - 7:45 AM

Ticketed Event

World Class Speakers

Discussion Leader

Silvia Vilarinho, MD, PhD

Yale University

Discussion Leader

Mitchell A Mah'moud, MD, FACG, AGAF, FAASLD

Duke University School of Medicine

Description

The presenters review emerging data regarding genomic analysis in the evaluation of adults with liver disease. The speakers discuss what categories of liver disease are enriched in genetic liver diseases and the importance of multidisciplinary forums to integrate genetic data with clinical impression. This session focuses on Wilson disease, hemochromatosis, and alpha-1 antitrypsin deficiency as well as the utility of genomics-informed hepatology.

Journey Maps

Hepatology Associates

Objectives

Delineate when the hepatologist should consider evaluation using genomic analysis.
Discuss the liver disease categories more enriched in genetic diseases.
Explain the concept of a multidisciplinary forum of "Hepatology Genome Rounds."